Post-earnings recap
Reported
Wed, Feb 3, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AbbVie reported an EPS of $2.92, which exceeded expectations, resulting in a positive stock reaction of 3.36%. However, there was no revenue data provided, and no guidance was issued. The market's response indicates investor confidence in AbbVie's earnings performance despite the lack of additional information.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.92 | N/A | +2.35% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.